Tobias Hägglöv
Director of Finance/CFO at ELEKTA AB
Net worth: 75 511 $ as of 2024-03-30
Profile
Tobias Hägglöv is currently the Chief Financial Officer at Elekta AB since 2022.
Prior to this, he was the Chief Financial Officer at Recipharm AB from 2018 to 2021, and at LEAX Group AB from 2017 to 2018.
He also worked as the Head-Group Business Control at Electrolux AB from 2012 to 2017 and as the Manager-Investor Relations at Scandinavian Airlines System SAS from 2007 to 2008.
Mr. Hägglöv graduated from the University of Stockholm and the Royal Institute of Technology in 2004.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ELEKTA AB CLASS B
0.00% | 2023-04-29 | 10,005 ( 0.00% ) | 75 511 $ | 2024-03-30 |
Tobias Hägglöv active positions
| Companies | Position | Start |
|---|---|---|
| ELEKTA AB | Director of Finance/CFO | 2022-01-31 |
Former positions of Tobias Hägglöv
| Companies | Position | End |
|---|---|---|
| RECIPHARM AB (PUBL) | Director of Finance/CFO | 2020-12-31 |
LEAX Group AB
 LEAX Group AB Industrial MachineryProducer Manufacturing LEAX Group AB manufactures mechanical and electromechanical components and part systems. The firm offers business consultancy services, which include implementation of management, quality, and environmental systems and project management services. The company was founded in 1984 and is headquartered in Koping, Sweden. | Director of Finance/CFO | 2017-12-31 |
| ELECTROLUX AB | Public Communications Contact | 2011-12-31 |
| Scandinavian Airlines System SAS | Investor Relations Contact | 2007-12-31 |
Training of Tobias Hägglöv
| University of Stockholm | Graduate Degree |
| Royal Institute of Technology | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ELECTROLUX AB | Consumer Durables |
| ELEKTA AB | Health Technology |
| Private companies | 3 |
|---|---|
Recipharm AB
 Recipharm AB BiotechnologyHealth Technology Recipharm AB engages in the manufacture of pharmaceuticals and contract development services for pharmaceutical companies. It operates through the following segments: Manufacturing Sterile and Inhalation (MFG-SI); Manufacturing Solids and Others (MFG-SO); Development and Technology (D&T); and Others and Eliminations. The MFG-SI segment includes manufacturing of products on behalf of pharmaceutical companies and covers sterile and inhalation technologies as well as liquid vials and ampoules, lyophilisates, blow-fill-seal products, and inhalation. The MFG-SO segment produces products on behalf of pharmaceutical companies and covers tablets, capsules, semi-solids, and non-sterile liquids. The D&T segment focuses on pharmaceutical development services. The company was founded by Lars Rickard Backsell and Thomas Bengt Eldered in 1995 and is headquartered in Stockholm, Sweden. | Health Technology |
LEAX Group AB
LEAX Group AB Industrial MachineryProducer Manufacturing LEAX Group AB manufactures mechanical and electromechanical components and part systems. The firm offers business consultancy services, which include implementation of management, quality, and environmental systems and project management services. The company was founded in 1984 and is headquartered in Koping, Sweden. | Producer Manufacturing |
| Scandinavian Airlines System SAS | Transportation |
- Stock Market
- Insiders
- Tobias Hägglöv
